Modulators of the integrated stress pathway
US-2024018133-A1 · Jan 18, 2024 · US
substituted by oxygen atoms
substituted by oxygen atoms · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D217/16 |
| Official title | substituted by oxygen atoms |
| Display label | substituted by oxygen atoms |
| Total patents | 127 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 22 |
| 2016 | 14 |
| 2017 | 14 |
| 2018 | 13 |
| 2019 | 16 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 12 |
| 2025 | 7 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulators
US-10106502-B2 · Oct 23, 2018 · US
Piperidine derivative and preparation method and pharmaceutical use thereof
US-10087191-B2 · Oct 2, 2018 · US
N-methyl-D-aspartate Receptor (NMDAR) Potentiators, Pharmaceutical Compositions, And Uses Related Thereto
US-2018244623-A1 · Aug 30, 2018 · US
Process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones
US-2018220689-A1 · Aug 9, 2018 · US
Pyridine derivatives
US-10005762-B2 · Jun 26, 2018 · US
Piperidine derivative and preparation method and pharmaceutical use thereof
US-2018170943-A1 · Jun 21, 2018 · US
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US-2018162847-A1 · Jun 14, 2018 · US
Process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones
US-9936723-B2 · Apr 10, 2018 · US
Novel compounds and compositions for inhibition of fasn
US-2018050997-A1 · Feb 22, 2018 · US
Compounds useful as immunomodulators
US-9850225-B2 · Dec 26, 2017 · US
Pyridine derivatives
US-2017362209-A1 · Dec 21, 2017 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2017340623-A1 · Nov 30, 2017 · US
Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
US-9815797-B2 · Nov 14, 2017 · US
Stereodynamic chemosensors
US-9815746-B2 · Nov 14, 2017 · US
PRMT5 inhibitors and uses thereof
US-9765068-B2 · Sep 19, 2017 · US
Inhibitors of the fibroblast growth factor receptor
US-2017253593-A1 · Sep 7, 2017 · US
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US-9745291-B2 · Aug 29, 2017 · US
Inhibitors of the fibroblast growth factor receptor
US-9695165-B2 · Jul 4, 2017 · US
IRE-1alpha INHIBITORS
US-2017152206-A1 · Jun 1, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D217/16?
- CPC C07D217/16 is the Cooperative Patent Classification code for “substituted by oxygen atoms.”
- How many patents are filed under CPC C07D217/16 (substituted by oxygen atoms)?
- Our database includes 127 publications tagged with this CPC code.
- Is patent activity under CPC C07D217/16 growing?
- Publication counts under this code: 12 in 2024 vs 7 in 2025 (latest complete years).